PubRank

R P Perrillo

Author PubWeight™ 71.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999 5.32
2 A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995 4.84
3 Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 1989 4.69
4 Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 4.59
5 Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992 3.01
6 Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993 2.20
7 Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001 2.13
8 Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995 2.07
9 Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995 2.00
10 Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 2004 1.61
11 Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993 1.43
12 Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus. Gastroenterology 1979 1.42
13 Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994 1.34
14 Colonic tuberculosis diagnosed by colonoscopic biopsy. Gastroenterology 1979 1.30
15 Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis 1990 1.29
16 Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998 1.22
17 Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 1994 1.20
18 Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance. Hepatology 1992 1.10
19 Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy. J Med Virol 1989 1.09
20 Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci 1997 1.04
21 Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med 1986 1.01
22 Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase. A combined clinical and pathological study. Am J Dig Dis 1978 0.97
23 Acute non-A, non-B hepatitis with serum sickness-like syndrome and aplastic anemia. JAMA 1981 0.96
24 Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 1985 0.95
25 Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis. Ann Intern Med 1984 0.94
26 Factors influencing response to interferon in chronic hepatitis B: implications for Asian and western populations. Hepatology 1990 0.93
27 Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses. Gastroenterology 1983 0.92
28 Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia? Hepatology 2001 0.92
29 Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment. Gastroenterology 1995 0.92
30 Hepatitis B and liver transplantation. Problems and promises. N Engl J Med 1993 0.90
31 Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group. J Viral Hepat 1994 0.88
32 Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases. J Viral Hepat 2014 0.87
33 Immunoregulatory T cell subsets in chronic hepatitis B virus infection: the influence of homosexuality. Hepatology 1983 0.86
34 The clinical course and chronic sequelae of hepatitis B virus infection. Semin Liver Dis 1981 0.85
35 Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy. Am J Gastroenterol 1996 0.83
36 Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results. Clin Transplant 2001 0.82
37 Comparison of quantitative HCV RNA assays in chronic hepatitis C. Am J Clin Pathol 1997 0.82
38 Discordant e antigen, DNA polymerase activity, and Dane particle responses in two patients representing an index case-contact case pair with hepatitis B virus infection. J Infect Dis 1977 0.81
39 Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group. Hepatology 1996 0.80
40 Immune globulin and hepatitis B immune globulin. Prophylactic measures for intimate contacts exposed to acute type B hepatitis. Arch Intern Med 1984 0.79
41 HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B. Hepatology 1991 0.79
42 Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group. J Hepatol 1990 0.79
43 Quantitative temporal analysis of 99mTechnetium p-isopropyl-iminodiacetic acid (PIPIDA) as a measure of hepatic function in health and disease. Gastroenterology 1981 0.79
44 The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C. Semin Liver Dis 1999 0.79
45 Filtration and immunoprecipitation in the elimination of DNA polymerase activity associated with bacterial contamination of sera positive for hepatitis B e antigen and its corresponding antibody. J Infect Dis 1978 0.79
46 Short-term corticosteroid therapy in combination with lamivudine: A case of déjà vu? Hepatology 2000 0.78
47 Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students. J Infect Dis 1984 0.78
48 The role of additives in allergic vasculitis during intravenous hyperalimentation. Am J Dig Dis 1975 0.78
49 Xenon-133 retention in hepatic steatosis-correlation with liver biopsy in 45 patients: concise communication. J Nucl Med 1979 0.76
50 Gastric pseudolymphoma. A spectrum of presenting features and diagnostic considerations. Am J Gastroenterol 1976 0.76
51 Case studies of the hepatitis B patient: a panel discussion. Semin Liver Dis 2000 0.76
52 Viral hepatitis management. Standards for the future. Case studies. Gut 1993 0.75
53 Prevaccination screening of medical and dental students. Should low levels of antibody to hepatitis B surface antigen preclude vaccination? JAMA 1983 0.75
54 Screening of health care workers before hepatitis B vaccination: more questions than answers. Ann Intern Med 1985 0.75
55 Suppression of T helper function: an immunoregulatory effect of rosette inhibitory factor in hepatitis B virus infection. Hepatology 1985 0.75
56 Oral cholecystography in chronic renal insufficiency. Am J Dig Dis 1978 0.75
57 A problem with a severed feeding tube. Gastrointest Endosc 1983 0.75
58 Corticosteroid therapy for chronic active hepatitis B: is a little to much? Hepatology 1987 0.75
59 A partial characterization of hepatitis B e antigen. J Infect Dis 1979 0.75
60 Clinical and immunologic features of chronic dialysis patients who fail to respond to hepatitis B vaccine. Vaccine 1985 0.75
61 Aberrant pancreas and leiomyoma of the stomach: indistinguishable radiologic and endoscopic features. Gastrointest Endosc 1977 0.75
62 Different operating conditions affect risk of hepatitis B virus infection at two residential institutions for the mentally disabled. Am J Epidemiol 1986 0.75
63 Prevalence of hepatitis B antibodies in personnel at a children's hospital. Pediatrics 1985 0.75
64 The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication. J Hepatol 1986 0.75
65 Rosette inhibitory factor (RIF) augments cyclic AMP generation by helper T lymphocytes. J Clin Lab Immunol 1986 0.75
66 Elevated HLA class I antigen expression on peripheral blood mononuclear cells of HBsAg carriers with coexistent human immunodeficiency virus infection. Hepatology 1988 0.75
67 Response to hepatitis B virus vaccine in subjects with low levels of antibody to hepatitis B surface antigen. N Engl J Med 1984 0.75
68 The A to Z of new hepatotropic agents: human hepatitis viruses and monkey business. Liver Transpl Surg 1996 0.75
69 Complementary use of computerized tomography and technetium scanning in the diagnosis of accessory spleen. Dig Dis Sci 1980 0.75
70 Rosette inhibitory factor: T-lymphocyte subpopulation specificity and potential immunoregulatory role in hepatitis B virus infection. Hepatology 1982 0.75
71 Should spouses of hepatitis B surface antigen carriers receive hepatitis vaccine? N Engl J Med 1983 0.75